COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 729: Articles 7281-7290  | Next

Modelling the role of quarantine escapees on COVID-19 dynamics
Mushanyu, J., Madubueze, C. E., Chazuka, Z., Chukwu, W., Ogbogbo, C.
10.1101/2022.07.30.22278240 — Posted: 2022-07-31
Institutional trust in times of Corona
Snel, E., El Farisi, B., Engbersen, G., Krouwel, A.
10.1101/2022.07.28.22278140 — Posted: 2022-07-31
Profiling post-COVID syndrome across different variants of SARS-CoV-2
Canas, L. S., Molteni, E., Deng, J., Sudre, C. H., Murray, B., Kerfoot, E., Antonelli, M., Chen, L., Rjoob, K., Pujol, J. C., Polidori, L., May, A., Osterdahl, M. F., Whiston, R., Cheetham, N. J., Bowyer, V., Spector, T. D., Hammers, A., Duncan, E. L., Ourselin, S., Steves, C. J., Modat, M.
10.1101/2022.07.28.22278159 — Posted: 2022-07-31
Two years after lockdown: longitudinal trajectories of sleep disturbances and mental health over the COVID-19 pandemic and the effects of age, gender, and chronotype.
Salfi, F., Amicucci, G., Corigliano, D., Viselli, L., D'Atri, A., Tempesta, D., Gorgoni, M., Scarpelli, S., Alfonsi, V., Ferrara, M.
10.1101/2022.07.29.22278180 — Posted: 2022-07-31
Sociodemographic factors affecting not receiving COVID-19 vaccine in Japan among people who originally intended to vaccinate: a prospective cohort study
Matsuyama, A., MORI, T., Ogami, A., Mafune, K., Tateishi, S., Kuwamura, M., Muramatsu, K., Fujino, Y., Mori, K.
10.1101/2022.07.29.22277984 — Posted: 2022-07-31
Confirmed SARS-CoV-2 infection in Scottish neonates 2020-2022: a national, population-based cohort study
Goulding, A., McQuaid, F., Lindsay, L., Agrawal, U., Auyeung, B., Calvert, C., Carruthers, J., Denny, C., Donaghy, J., Hillman, S., Hopcroft, L., Hopkins, L., McCowan, C., Mclaughlin, T., Moore, E., Ritchie, L., Simpson, C. R., Taylor, B., Fenton, L., Pollock, L., Gale, C., Kurinczuk, J. J., Robertson, C., Sheikh, A., Stock, S., Wood, R.
10.1101/2022.07.28.22278152 — Posted: 2022-07-31
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022
Seekircher, L., Siller, A., Astl, M., Tschiderer, L., Wachter, G. A., Pfeifer, B., Huber, A., Gaber, M., Schennach, H., Willeit, P.
10.1101/2022.07.28.22278141 — Posted: 2022-07-31
Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply
Galli, M., Zardini, A., Nigussa Gamshie, W., Santini, S., Tsegaye, A., Trentini, F., Marziano, V., Guzzetta, G., Manica, M., d'Andrea, V., Putoto, G., Manenti, F., Ajelli, M., Poletti, P., Merler, S.
10.1101/2022.07.28.22278142 — Posted: 2022-07-31
The Efficacy of Facemasks in the Prevention of COVID-19: A Systematic Review
Alihsan, B., Mohammed, A., Bisen, Y., Lester, J., Nouryan, C., Cervia, J. S.
10.1101/2022.07.28.22278153 — Posted: 2022-07-31
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021
Gallian, P., Hoze, N., Brisbarre, N., Mariela Saba Villarroel, P., Nurtop, E., Isnard, C., Pastorino, B., Richard, P., Morel, P., Cauchemez, S., de Lamballerie, X.
10.1101/2022.07.29.22278190 — Posted: 2022-07-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).